Report Cases Of Adverse Drug Reactions — AkunyiliReport Cases Of Adverse Drug Reactions — Akunyili
Nigerians have been urged to always report cases of adverse drug
reactions to relevant authorities in other to help the agency achieve
its aims. This was disclosed as the World Health Organization (WHO)
collaborating centre for International Drug Monitoring showered
encomium on the National Agency for Food and Drug Administration and
Control (NAFDAC) for coordinating an effective Pharmacovigilance System
in Nigeria .
With a total of 725 Adverse Drug Reaction (ADR) cases reported to the
WHO Drug Monitoring Centre in Uppsala, Sweden since inception in
September, 2004, NAFDAC's Pharmacovigilance Centre is regarded by the
WHO as “one of the most active and dynamic pharmacovigilance centre in
Africa right now”.
The WHO's Chief Programme Officer, Uppsala Monitoring Centre, Mr. Sten
Olsson who had been visibly impressed with NAFDAC's 4-years track
record of performance said Nigeria 's Pharmacovigilance (ADR
Monitoring) submission will be published in the next report of Uppsala
collaborating centre.
Mr. Olsson said such publication will show case NAFDAC's
Pharmacovigilance Centre as “good model” for other countries to
emulate.
He noted that in spite of the comparative successes recorded by
Nigeria there are still rooms for improvement as most successful ADR
Centres have taken 30-40 years to attain their present Olympian height.
The WHO Chief implored the Agency not to be discouraged by the
frustration posed by the low level ADR reporting system among Nigerian
Healthcare professionals noting that is a manifestation characterizing
young Pharmacovigilance Centres.
Director-General of NAFDAC, Prof. Dora Akunyili said the WHO's
commendation is “stimulating and has given the Agency the required
impetus to achieve more successes in pharmacovigilance reporting next
year”.
Prof. Akunyili disclosed that the Agency will soon embark on vigorous
public enlightenment campaign and advocacy visits to Hospitals, Clinics
and Health Centres nationwide to increase the level of ADR reporting
among Healthcare professionals.
` She however urged the mass media to join the sensitization
campaign because of the low level of public awareness on the imperative
of reporting cases of Adverse Drug Reactions.
|